Skip to product information
1 of 4

NI PEPTIDES LTD

GLPT 40 DCX Dual Chamber Pen

GLPT 40 DCX Dual Chamber Pen

Regular price £160.00 GBP
Regular price Sale price £160.00 GBP
Sale Sold out
Taxes included.
Quantity

🧪 DCX Dual Chamber Exchange System – 40mg Tirzepatide Pen

Research Grade

Ā 

🧾 PRODUCT OVERVIEW

Research Use Only – Not for Human or Animal Consumption

The DCX Dual Chamber Exchange System – 40mg Tirzepatide Pen is a compartmentalised research peptide system supplied for laboratory and in-vitro research purposes only.

This dual-chamber format is designed for controlled experimental investigation in laboratory environments, where separated material storage and controlled exchange processes may be evaluated within defined research models.

NI Peptides supplies this product exclusively as a research material and does not market it as a medicinal product.

Ā 

āš—ļø TECHNICAL SPECIFICATION

  • Compound: Tirzepatide
  • System Type: DCX Dual Chamber Exchange System
  • Format: Dual-chamber research pen system
  • Class: Synthetic peptide analogue
  • Quantity: 40mg
  • Appearance: White/off-white lyophilised material
  • Purity: ≄ 98%
  • Storage: Store in a cool, dry environment
  • Post-activation storage: 2–8°C (where applicable)

Ā 

šŸ”¬ DCX DUAL CHAMBER SYSTEM

The DCX Dual Chamber Exchange System utilises a separated dual-chamber configuration designed to maintain compartmentalisation of materials within a controlled laboratory setting.

This research format allows investigation into:

  • compartmentalised storage environments
  • controlled material separation
  • peptide stability under isolated conditions
  • exchange and activation processes within experimental systems

The dual-chamber design is intended for research applications where controlled handling and separated storage conditions are required during laboratory investigation.

All references to the DCX system relate strictly to non-clinical laboratory research functionality.

NI Peptides makes no representation regarding:

  • biological application
  • therapeutic use
  • clinical utility
  • diagnostic application

Ā 

šŸ”¬ RESEARCH CONTEXT

Tirzepatide is a peptide structure referenced within scientific literature and studied in laboratory environments in relation to peptide–receptor interaction models and molecular signalling pathways.

In controlled research settings, this compound may be used to investigate:

  • receptor-mediated signalling pathways
  • peptide interaction dynamics
  • molecular and biochemical behaviour within experimental systems

Research involving this compound is conducted strictly in non-clinical environments.

NI Peptides makes no representation regarding:

  • biological effects in humans or animals
  • clinical relevance
  • therapeutic or diagnostic application

All references to research relate strictly to experimental scientific investigation.

Ā 

āš ļø IMPORTANT COMPLIANCE NOTICE

  • This product is NOT intended for human or veterinary use
  • This product is NOT a medicine
  • This product is not authorised as a medicinal product
  • This product has not been evaluated or approved by the MHRA
  • This product is NOT intended to diagnose, treat, cure, or prevent any disease

Any use outside legitimate laboratory research is strictly prohibited.

Ā 

šŸ§‘ā€šŸ”¬ PURCHASER DECLARATION

By purchasing this product, you confirm that:

  • You are acquiring this product for research purposes only
  • You are familiar with laboratory research practices
  • You understand this product is not for human or animal administration
  • You will comply with all applicable laws and regulations

Ā 

🧊 HANDLING & STORAGE

  • Handle using appropriate laboratory procedures
  • Avoid repeated temperature fluctuation
  • Store under controlled laboratory conditions
  • Keep out of reach of unauthorised individuals

Ā 

🚚 SHIPPING & PACKAGING

  • Secure, discreet packaging
  • Sealed research system to maintain product integrity
  • Batch identification where applicable

Ā 

šŸ”’ QUALITY ASSURANCE

Each batch is prepared in accordance with internal standards for research-grade materials.

Batch / purity data may be available upon request where applicable.

Ā 

ā— DISCLAIMER

NI Peptides supplies the DCX Dual Chamber Exchange System strictly as a research compound system.

We do not:

  • provide dosage or administration guidance
  • make claims regarding outcomes or efficacy
  • endorse any use outside laboratory research
View full details

DISCLAIMER

All products sold on this website areĀ intended for laboratory research use onlyĀ and areĀ not for human consumption, veterinary use, or diagnostic purposes. These products areĀ not medicines, drugs, or food supplements, and haveĀ not been evaluated, approved, or endorsedĀ by any regulatory authority including the MHRA, FDA, or EMA.

By purchasing from this website, you acknowledge that:

  • You are aĀ qualified researcherĀ or purchasing on behalf of a research organization.
  • You understand the potential hazards associated with handling research chemicals.
  • You agree toĀ handle, store, and disposeĀ of all materials safely and responsibly, in accordance with applicable laws and regulations.
  • You willĀ not use these products for any form of human or animal application, including ingestion, injection, topical use, or inhalation.

NI PEPTIDESĀ accepts no responsibilityĀ for misuse of any products sold. Purchasing constitutes acceptance of this disclaimer and theĀ Terms & ConditionsĀ of sale.